Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: MiniMed/Boehringer Mannheim

This article was originally published in The Gray Sheet

Executive Summary

MiniMed/Boehringer Mannheim: Firms enter co-marketing agreement, effective June 1, under which the firms' sales and marketing forces will cooperate in promoting their diabetes care products in the U.S. The firms will create a joint sales and marketing "council" to develop "promotional materials and sales strategies" for U.S. operations, MiniMed says. The deal brings together Boehringer, the largest producer of glucose meters and test strips worldwide and the second largest producer of in vitro diagnostics, and MiniMed, which markets lines of external infusion systems for diabetes management in the U.S. and sells implantable infusion devices overseas. MiniMed also plans to commence multicenter clinical trials of a minimally-invasive subcutaneous glucose monitor in late 1996...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel